Pacific Biosciences of California(US:PACB)2026-01-12 14:07Financial Results - Pacific Biosciences of California, Inc. announced preliminary financial results for the quarter and year ended December 31, 2025[4]. - The financial statements for the quarter and year ended December 31, 2025, have not yet been finalized or audited, indicating potential changes in final results[8]. - The financial information provided is preliminary and should not be relied upon without further confirmation[8]. Revenue Expectations - The company expects preliminary revenue estimates for the quarter to be significantly impacted by market conditions[6]. - Cash, cash equivalents, and investments balance as of December 31, 2025, are anticipated to be lower than previous estimates[6]. Company Classification and Stock Information - The company is classified as an emerging growth company under the Securities Act[3]. - Pacific Biosciences' common stock is traded on the NASDAQ under the symbol PACB[2]. Company Details - The company is headquartered in Menlo Park, California[1]. - The press release detailing these updates was issued on January 12, 2026[4]. - The company has not elected to use the extended transition period for complying with new financial accounting standards[3].